FDA Import Refusal 1FX-6752812-5/10002/1 — Exemed Pharmaceuticals
The FDA refused shipment 1FX-6752812-5/10002/1 from Exemed Pharmaceuticals (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61NDA78 SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT)
- Charges
- 75